Ainos Inc (AIMD)

$0.50 0.00 (-0.08%)
Market Cap 10.47M
Revenue (ttm) 20,000.00
Net Income (ttm) -14.86M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -74,300.00%
Debt to Equity Ratio 0.08
Volume 84,100
Avg Vol 268,286
Day's Range N/A - N/A
Shares Out 20.76M
Stochastic %K 7%
Beta 2.20
Analysts Strong Buy
Price Target N/A

Company Profile

Ainos, Inc., a healthcare company, focuses on the development of novel point-of-care testing therapeutics based on very low-dose interferon alpha and synthetic RNA-driven preventative medicine. The company provides COVID-19 antigen rapid test kit and VELDONA pet supplement, a health issues in dogs and cats, including skin, gum, emotion, discomfort caused by allergies, eye, and weight-related issues. It offers VELDONA human and animal drugs, a human drug pipeline includes treatments for oral wart...

Industry: Medical Devices
Sector: Healthcare
Phone: 858 869 2986
Address:
8880 Rio San Diego Drive, Suite 800, San Diego, United States
SilverTongue
SilverTongue Jun. 17 at 3:06 AM
$AIMD
0 · Reply
TechFan6
TechFan6 Jun. 16 at 5:54 PM
$AIMD Mid-Year Milestone Update from AIMD • AI Nose enters scaled pilots in healthcare, robotics & semiconductors • VELDONA® cleared for human trials in Taiwan • 412% YoY rev growth driven by Japan senior care • Strategic expansion + global visibility (Forbes, Bloomberg, Computex) Smell is the next AI frontier—and Ainos is leading it. 👇 https://feeds.issuerdirect.com/news-release.html?newsid=5266514651967879&symbol=AIMD #SmellTech #AINose #VELDONA #AIMD #AI #Healthcare #Robotics #Semiconductors
1 · Reply
Tunes444
Tunes444 Jun. 16 at 4:05 PM
$AIMD up 5%
0 · Reply
LebronBOOM
LebronBOOM Jun. 16 at 4:02 PM
$AIMD
0 · Reply
PaoloWorld
PaoloWorld Jun. 16 at 3:59 PM
$AIMD Insane to think smell is becoming machine-readable
0 · Reply
BigRodddd
BigRodddd Jun. 16 at 3:58 PM
$AIMD
0 · Reply
Ferg500
Ferg500 Jun. 16 at 3:57 PM
$AIMD shipped modules to Japan, partnered with ASE for factory integration, and launched the world’s first robotic smell platform. AI Nose just hit real-world testing mode.
0 · Reply
Fidely
Fidely Jun. 16 at 3:53 PM
$AIMD VELDONA® moving into human trials in Taiwan
0 · Reply
Stoness5687
Stoness5687 Jun. 16 at 3:52 PM
$AIMD set to pilot across prioritized sites. 30+ use cases already mapped out.
0 · Reply
StocksPlusStuffers
StocksPlusStuffers Jun. 16 at 3:51 PM
$AIMD is one of the few microcaps showing real revenue traction from AI tech.
0 · Reply
Latest News on AIMD
Ainos Issues Mid-Year Update: Reaching Strategic Inflection in SmellTech and Immunotherapy

Jun 16, 2025, 8:00 AM EDT - 15 hours ago

Ainos Issues Mid-Year Update: Reaching Strategic Inflection in SmellTech and Immunotherapy

Water Tower Research Highlights Ainos' AI Nose Accuracy Breakthrough in Elderly Care Monitoring: SmellTech Gets Smarter

Jun 3, 2025, 8:00 AM EDT - 13 days ago

Water Tower Research Highlights Ainos' AI Nose Accuracy Breakthrough in Elderly Care Monitoring: SmellTech Gets Smarter

Ainos AI Nose Improves Accuracy in Hygiene Monitoring To 85% from 80%

May 29, 2025, 8:00 AM EDT - 18 days ago

Ainos AI Nose Improves Accuracy in Hygiene Monitoring To 85% from 80%

Ainos Showcases Breakthrough AI Nose Technology at COMPUTEX 2025 with Japan's Robotics Partner

May 22, 2025, 8:00 AM EDT - 25 days ago

Ainos Showcases Breakthrough AI Nose Technology at COMPUTEX 2025 with Japan's Robotics Partner

Ainos Reports Breakthrough Interim Results in VELDONA Clinical Trial for FCGS, Signaling New Era in Companion Animal Immunotherapy

May 19, 2025, 8:00 AM EDT - 4 weeks ago

Ainos Reports Breakthrough Interim Results in VELDONA Clinical Trial for FCGS, Signaling New Era in Companion Animal Immunotherapy

Water Tower Research Highlights Ainos' Significant Commercial Traction and Strategic Milestones Across Multiple Sectors

May 14, 2025, 8:00 AM EDT - 4 weeks ago

Water Tower Research Highlights Ainos' Significant Commercial Traction and Strategic Milestones Across Multiple Sectors

Ainos Reports First Quarter 2025 Financial Results

May 12, 2025, 8:00 AM EDT - 5 weeks ago

Ainos Reports First Quarter 2025 Financial Results

Ainos Forms Partnership with ASE's Key Site to Power AI-Driven SmellTech in Semiconductor Smart Manufacturing

Apr 30, 2025, 8:12 AM EDT - 6 weeks ago

Ainos Forms Partnership with ASE's Key Site to Power AI-Driven SmellTech in Semiconductor Smart Manufacturing

ASX

Water Tower Research Spotlights Ainos' Smell Integration in Humanoid Robot - AI Smelltech is Progressing Rapidly

Apr 23, 2025, 8:00 AM EDT - 7 weeks ago

Water Tower Research Spotlights Ainos' Smell Integration in Humanoid Robot - AI Smelltech is Progressing Rapidly

Ainos and ugo Complete First Robotic Smell Integration in Japan

Apr 21, 2025, 8:00 AM EDT - 2 months ago

Ainos and ugo Complete First Robotic Smell Integration in Japan

Ainos Secures TFDA Approval and IRB Clearance to Advance VELDONA Clinical Trials for HIV Oral Warts and Sjögren's Syndrome in Taiwan

Apr 14, 2025, 8:00 AM EDT - 2 months ago

Ainos Secures TFDA Approval and IRB Clearance to Advance VELDONA Clinical Trials for HIV Oral Warts and Sjögren's Syndrome in Taiwan

Water Tower Research Highlights Ainos' AI Nose Expansion into Robotics and Semiconductor Manufacturing - Smell ID Is Scaling

Apr 11, 2025, 8:00 AM EDT - 2 months ago

Water Tower Research Highlights Ainos' AI Nose Expansion into Robotics and Semiconductor Manufacturing - Smell ID Is Scaling

Ainos to Participate in Fireside Chat with Water Tower Research on April 8, 2025

Mar 24, 2025, 5:00 PM EDT - 3 months ago

Ainos to Participate in Fireside Chat with Water Tower Research on April 8, 2025

Water Tower Research Spotlights Ainos & ASE Partnership: Unleashing AI Nose's Potential in Chip Manufacturing and More

Mar 13, 2025, 9:00 AM EDT - 3 months ago

Water Tower Research Spotlights Ainos & ASE Partnership: Unleashing AI Nose's Potential in Chip Manufacturing and More

ASX

Ainos and ASE Partner to Power AI Scent Digitization in Semiconductor Manufacturing

Mar 11, 2025, 9:00 AM EDT - 3 months ago

Ainos and ASE Partner to Power AI Scent Digitization in Semiconductor Manufacturing

ASX

Ainos Reports Full Year 2024 Financial Results

Mar 7, 2025, 4:45 PM EST - 3 months ago

Ainos Reports Full Year 2024 Financial Results

Water Tower Research Highlights Ainos & ugo Partnership: The Final Sense for Robots - AI Smell is Here

Mar 7, 2025, 1:30 PM EST - 3 months ago

Water Tower Research Highlights Ainos & ugo Partnership: The Final Sense for Robots - AI Smell is Here

Ainos and ugo to Develop the World's First Robot With a Sense of Smell

Mar 5, 2025, 10:00 AM EST - 3 months ago

Ainos and ugo to Develop the World's First Robot With a Sense of Smell

Ainos Achieves Major Breakthrough: Japan Patent Approval for VELDONA Redefines Antiviral Innovation

Jan 27, 2025, 10:00 AM EST - 5 months ago

Ainos Achieves Major Breakthrough: Japan Patent Approval for VELDONA Redefines Antiviral Innovation

Water Tower Research Spotlights Ainos' AI Nose Programs and Strategic Milestones for 2025

Jan 21, 2025, 10:00 AM EST - 5 months ago

Water Tower Research Spotlights Ainos' AI Nose Programs and Strategic Milestones for 2025

Ainos Granted 180-Day Extension by Nasdaq to Regain Compliance With Minimum Bid Price Rule

Jan 17, 2025, 9:00 AM EST - 5 months ago

Ainos Granted 180-Day Extension by Nasdaq to Regain Compliance With Minimum Bid Price Rule

Ainos Unveils AI Nose for Robotics: Invites Global Robotics Companies to Join Forces in Shaping the Future of Smell-Enabled Robots

Jan 13, 2025, 10:00 AM EST - 5 months ago

Ainos Unveils AI Nose for Robotics: Invites Global Robotics Companies to Join Forces in Shaping the Future of Smell-Enabled Robots

CORRECTION BY SOURCE: Smell the Future: Ainos Elevates Health and Technology With AI Nose and VELDONA

Dec 18, 2024, 12:05 PM EST - 6 months ago

CORRECTION BY SOURCE: Smell the Future: Ainos Elevates Health and Technology With AI Nose and VELDONA

Smell the Future: Ainos Elevates Health and Technology With AI Nose and VELDONA

Dec 18, 2024, 8:00 AM EST - 6 months ago

Smell the Future: Ainos Elevates Health and Technology With AI Nose and VELDONA

Ainos Joins Webull Corporate Connect Service Platform to Enhance Investor Engagement

Dec 13, 2024, 8:00 AM EST - 6 months ago

Ainos Joins Webull Corporate Connect Service Platform to Enhance Investor Engagement

Water Tower Research Underscores Ainos' Partnership With Taiwan Tanabe Seiyaku for VELDONA Manufacturing and Marketing

Dec 4, 2024, 8:00 AM EST - 6 months ago

Water Tower Research Underscores Ainos' Partnership With Taiwan Tanabe Seiyaku for VELDONA Manufacturing and Marketing

Ainos, Inc. Announces Strategic Partnership with Taiwan Tanabe Seiyaku to Advance Manufacturing and Taiwan Market Promotion of Sjögren's Syndrome Drug

Dec 2, 2024, 8:00 AM EST - 7 months ago

Ainos, Inc. Announces Strategic Partnership with Taiwan Tanabe Seiyaku to Advance Manufacturing and Taiwan Market Promotion of Sjögren's Syndrome Drug

Water Tower Research Highlights IRB Approval for the Ainos VELDONA Clinical Sjogren's Trial Alongside 3Q24 Earnings and Developments

Nov 13, 2024, 8:00 AM EST - 7 months ago

Water Tower Research Highlights IRB Approval for the Ainos VELDONA Clinical Sjogren's Trial Alongside 3Q24 Earnings and Developments

Ainos Announces IRB Approval for Sjögren's Syndrome Clinical Study at Shuang Ho Hospital, Affiliated with Taipei Medical University, and Plans to Initiate New Phase of Treatment Evaluation in Q1 2025

Nov 11, 2024, 8:00 AM EST - 7 months ago

Ainos Announces IRB Approval for Sjögren's Syndrome Clinical Study at Shuang Ho Hospital, Affiliated with Taipei Medical University, and Plans to Initiate New Phase of Treatment Evaluation in Q1 2025

Ainos Takes Decisive Action to Protect Stockholder Interests and Combat Potential Illegal Trading Activities

Nov 8, 2024, 8:00 AM EST - 7 months ago

Ainos Takes Decisive Action to Protect Stockholder Interests and Combat Potential Illegal Trading Activities

Ainos Reports Third Quarter 2024 Financial Results

Nov 6, 2024, 4:30 PM EST - 7 months ago

Ainos Reports Third Quarter 2024 Financial Results

Ainos Expands Patent Portfolio With Strategic Shareholder's Cutting-Edge Technology Assets

Oct 28, 2024, 8:00 AM EDT - 8 months ago

Ainos Expands Patent Portfolio With Strategic Shareholder's Cutting-Edge Technology Assets

Ainos Highlights VELDONA Clinical Advancements and Market Potential in Water Tower Research Spotlight Podcast

Oct 24, 2024, 10:50 AM EDT - 8 months ago

Ainos Highlights VELDONA Clinical Advancements and Market Potential in Water Tower Research Spotlight Podcast

Ainos Advances Healthcare and Industrial Innovations with AI Nose and VELDONA Technologies

Oct 7, 2024, 8:00 AM EDT - 9 months ago

Ainos Advances Healthcare and Industrial Innovations with AI Nose and VELDONA Technologies

Ainos, Inc. Receives IRB Approval From National Taiwan University Hospital for HIV-Oral Warts Clinical Trial, Highlighting Value of FDA-Designated Orphan Drug VELDONA

Sep 25, 2024, 8:00 AM EDT - 9 months ago

Ainos, Inc. Receives IRB Approval From National Taiwan University Hospital for HIV-Oral Warts Clinical Trial, Highlighting Value of FDA-Designated Orphan Drug VELDONA

Ainos Spotlighted in Water Tower Research Report on VELDONA Clinical Study for Sjogren's Syndrome

Sep 24, 2024, 10:55 AM EDT - 9 months ago

Ainos Spotlighted in Water Tower Research Report on VELDONA Clinical Study for Sjogren's Syndrome

Ainos Announced Plan to Initiate Taiwan Clinical Study of VELDONA for Treating Sjögren's Syndrome, a Rare Disease With Limited Treatment Options

Sep 23, 2024, 8:00 AM EDT - 9 months ago

Ainos Announced Plan to Initiate Taiwan Clinical Study of VELDONA for Treating Sjögren's Syndrome, a Rare Disease With Limited Treatment Options

Water Tower Research Highlights Ainos VELDONA Clinical Trial for HIV+ Patients with Oral Warts

Sep 20, 2024, 8:00 AM EDT - 9 months ago

Water Tower Research Highlights Ainos VELDONA Clinical Trial for HIV+ Patients with Oral Warts

Ainos Announced Plan to Initiate Taiwan Clinical Study for VELDONA as Potential Treatment of Oral Warts in HIV-Seropositive Patients, an Orphan Drug Designated by the FDA

Sep 17, 2024, 8:00 AM EDT - 9 months ago

Ainos Announced Plan to Initiate Taiwan Clinical Study for VELDONA as Potential Treatment of Oral Warts in HIV-Seropositive Patients, an Orphan Drug Designated by the FDA

Ainos Secures Taiwan Invention Patent and Advances Global Patent Protection for VELDONA, a Breakthrough in Coronavirus Treatment and Prevention

Sep 3, 2024, 8:30 AM EDT - 10 months ago

Ainos Secures Taiwan Invention Patent and Advances Global Patent Protection for VELDONA, a Breakthrough in Coronavirus Treatment and Prevention

Ainos to Participate in H.C. Wainwright 26th Annual Global Investment Conference

Aug 27, 2024, 8:30 AM EDT - 10 months ago

Ainos to Participate in H.C. Wainwright 26th Annual Global Investment Conference

Ainos CEO Highlights AI Nose Achievements and Upcoming 2H 2024 Milestones in Shareholder Letter

Aug 26, 2024, 8:30 AM EDT - 10 months ago

Ainos CEO Highlights AI Nose Achievements and Upcoming 2H 2024 Milestones in Shareholder Letter

Ainos Unveils AI Nose Breakthrough that Revolutionizes Smart Manufacturing Factory Automation and Manufacturing Safety

Aug 19, 2024, 9:15 AM EDT - 10 months ago

Ainos Unveils AI Nose Breakthrough that Revolutionizes Smart Manufacturing Factory Automation and Manufacturing Safety

Ainos to Participate in Fireside Chat with Water Tower Research on August 22, 2024

Aug 12, 2024, 8:00 AM EDT - 11 months ago

Ainos to Participate in Fireside Chat with Water Tower Research on August 22, 2024

Ainos Secures Exclusive Multi-Regions Invention Patent Licenses from Strategic Partner to Bolster AI Nose and Point-Of-Care Testing

Aug 9, 2024, 4:15 PM EDT - 11 months ago

Ainos Secures Exclusive Multi-Regions Invention Patent Licenses from Strategic Partner to Bolster AI Nose and Point-Of-Care Testing

Ainos Concludes Growth Financing From Lind Partners

Aug 6, 2024, 7:30 AM EDT - 11 months ago

Ainos Concludes Growth Financing From Lind Partners

Ainos Reports Second Quarter 2024 Financial Results

Aug 5, 2024, 4:15 PM EDT - 11 months ago

Ainos Reports Second Quarter 2024 Financial Results

Ainos Enrolls First Subject for Clinical Study of VELDONA-Based Animal FCGS Drug

Jul 23, 2024, 8:30 AM EDT - 11 months ago

Ainos Enrolls First Subject for Clinical Study of VELDONA-Based Animal FCGS Drug

Ainos Unveils Critical Progress in Ainos Flora Clinical Trials and Next-Gen Plans Powered by NVIDIA CUDA

Jun 14, 2024, 8:00 AM EDT - 1 year ago

Ainos Unveils Critical Progress in Ainos Flora Clinical Trials and Next-Gen Plans Powered by NVIDIA CUDA

Ainos to Initiate Clinical Study of New Potential VELDONA-Based Animal Drug, Expanding VELDONA's Potential Market

May 15, 2024, 8:00 AM EDT - 1 year ago

Ainos to Initiate Clinical Study of New Potential VELDONA-Based Animal Drug, Expanding VELDONA's Potential Market

SilverTongue
SilverTongue Jun. 17 at 3:06 AM
$AIMD
0 · Reply
TechFan6
TechFan6 Jun. 16 at 5:54 PM
$AIMD Mid-Year Milestone Update from AIMD • AI Nose enters scaled pilots in healthcare, robotics & semiconductors • VELDONA® cleared for human trials in Taiwan • 412% YoY rev growth driven by Japan senior care • Strategic expansion + global visibility (Forbes, Bloomberg, Computex) Smell is the next AI frontier—and Ainos is leading it. 👇 https://feeds.issuerdirect.com/news-release.html?newsid=5266514651967879&symbol=AIMD #SmellTech #AINose #VELDONA #AIMD #AI #Healthcare #Robotics #Semiconductors
1 · Reply
Tunes444
Tunes444 Jun. 16 at 4:05 PM
$AIMD up 5%
0 · Reply
LebronBOOM
LebronBOOM Jun. 16 at 4:02 PM
$AIMD
0 · Reply
PaoloWorld
PaoloWorld Jun. 16 at 3:59 PM
$AIMD Insane to think smell is becoming machine-readable
0 · Reply
BigRodddd
BigRodddd Jun. 16 at 3:58 PM
$AIMD
0 · Reply
Ferg500
Ferg500 Jun. 16 at 3:57 PM
$AIMD shipped modules to Japan, partnered with ASE for factory integration, and launched the world’s first robotic smell platform. AI Nose just hit real-world testing mode.
0 · Reply
Fidely
Fidely Jun. 16 at 3:53 PM
$AIMD VELDONA® moving into human trials in Taiwan
0 · Reply
Stoness5687
Stoness5687 Jun. 16 at 3:52 PM
$AIMD set to pilot across prioritized sites. 30+ use cases already mapped out.
0 · Reply
StocksPlusStuffers
StocksPlusStuffers Jun. 16 at 3:51 PM
$AIMD is one of the few microcaps showing real revenue traction from AI tech.
0 · Reply
RandomlySelected
RandomlySelected Jun. 16 at 3:47 PM
$AIMD Ongoing trials for feline oral disease showing symptom relief and no side effects
0 · Reply
ThoughtsOnThis
ThoughtsOnThis Jun. 16 at 3:47 PM
$AIMD ELDONA®, their oral interferon, just got greenlit to begin human trials in Taiwan for HIV-related oral warts and Sjögren’s syndrome. First patients set to enroll this year.
0 · Reply
MagelaMason
MagelaMason Jun. 16 at 3:45 PM
$AIMD now running robotic smell tests with Japan’s ugo Inc. First robot equipped with AI Nose launched in April. Field testing public infrastructure sites next.
0 · Reply
DarcyF
DarcyF Jun. 16 at 3:43 PM
$AIMD
0 · Reply
OptimistFrank851
OptimistFrank851 Jun. 16 at 3:38 PM
$AIMD shipped its first AI Nose units to Japan for hygiene monitoring in senior care. Accuracy hit 85% on 2,000+ samples. Pilots in robotics and smart factories next.
0 · Reply
Viiinnkkaa
Viiinnkkaa Jun. 16 at 3:34 PM
$AIMD just reported 412% YoY revenue growth in Q1, driven by their AI Nose tech in Japan’s senior care space. Now expanding into pilot programs across healthcare, robotics, and semiconductors. Execution is officially underway.
0 · Reply
Tunes444
Tunes444 Jun. 16 at 3:19 PM
$AIMD
0 · Reply
SilverTongue
SilverTongue Jun. 16 at 1:57 PM
$AIMD
0 · Reply
SmartTradeusa
SmartTradeusa Jun. 16 at 12:08 PM
$AIMD Ainos has received Taiwan Food and Drug Administration (TFDA) approval to begin clinical trials for its VELDONA® oral interferon therapy targeting: • HIV-related oral warts • Trial to start in June 2025 at National Taiwan University Hospital • Enrolling ~40 HIV-positive participants undergoing antiretroviral therapy • Expected trial completion in 2H 2026    • Primary Sjögren’s Syndrome (pSS) • Institutional Review Board (IRB) clearance received • TFDA approval anticipated by August 2025, with enrollment and completion planned for 2027 
0 · Reply
CupShaker
CupShaker Jun. 13 at 8:14 PM
$AIMD thoroughly fleeced all week
0 · Reply
TechFan6
TechFan6 Jun. 13 at 7:18 PM
$AIMD Japan has more elderly than any country on Earth and doesn’t have enough caregivers. AI Nose stepping in isn’t just smart business. It’s helping a society under pressure stay clean, healthy, and human.
0 · Reply
TechFan6
TechFan6 Jun. 13 at 5:39 PM
$AIMD Most caregivers won’t say it out loud, but checking for accidents, odor, or infections in elder care is one of the hardest parts of the job. AI Nose does it instantly—no awkwardness, no guesswork. Just dignity, safety, and peace of mind.
0 · Reply